Literature DB >> 8568214

Vasopressin- and oxytocin-like systems in the chameleon brain.

M Bennis1, A M Tramu, J Repérant.   

Abstract

The distribution of vasopressin (VP)-like and oxytocin (OX)-like immunoreactivities was investigated in the chameleon brain with antisera specific for either peptide. VP-like and OX-like neurons are found only in two nuclei: in the supraoptic and in the paraventricular nuclei, whereas both peptidergic innervations are restricted to some ventral areas, especially to the hypothalamus. However, in these areas, OX-like innervation is less dense than the VP-like innervation. Even though, no sex differences were noted for the two systems, differences are present between the normal female and the preoviposit one concerning VP-like system. In the latter female, numerous VPergic-like cell bodies occurred in the ependymal layer, making likely direct contact with the cerebrospinal fluid (CSF) of the third ventricle. In addition, some VP-like nerve fibers seem to be in supraependymal position at the septal wall, probably also in contact with CSF.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8568214

Source DB:  PubMed          Journal:  J Hirnforsch        ISSN: 0021-8359


  3 in total

1.  Selective specificity of calcium-binding proteins calbindin and calretinin expression in the magnocellular neurosecretory hypothalamic nuclei of tortoises and turtles.

Authors:  M G Belekhova; N B Kenigfest; E V Chernigovskaya; N P Veselkin
Journal:  Dokl Biol Sci       Date:  2017-05-16

Review 2.  Sexual differentiation of central vasopressin and vasotocin systems in vertebrates: different mechanisms, similar endpoints.

Authors:  G J De Vries; G C Panzica
Journal:  Neuroscience       Date:  2005-11-28       Impact factor: 3.590

3.  Distribution of vasotocin- and vasoactive intestinal peptide-like immunoreactivity in the brain of blue tit (Cyanistes coeruleus).

Authors:  Catherine M Montagnese; Tamás Székely; András Csillag; Gergely Zachar
Journal:  Front Neuroanat       Date:  2015-07-14       Impact factor: 3.856

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.